Format
Items per page
Sort by

Send to:

Choose Destination

Results: 1 to 20 of 67

1.

[Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management: differences between the European and American Guidelines].

Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR; Comité Español Interdisciplinario para la Prevención de la Enfermedad Cardiovascular; Sociedad Española de Cardiología.

Rev Esp Salud Publica. 2015 Feb;89(1):15-26. doi: 10.4321/S1135-57272015000100003. Spanish.

2.

[Secondary prevention of ischemic non cardioembolic stroke].

Armario P, Pinto X, Soler C, Cardona P.

Clin Investig Arterioscler. 2015 Mar 11. pii: S0214-9168(15)00010-8. doi: 10.1016/j.arteri.2015.01.006. [Epub ahead of print] Spanish.

PMID:
25771074
3.

[Spanish interdisciplinary committee for cardiovascular disease prevention and the spanish society of cardiology position statement on dyslipidemia management. Differences between the European and american guidelines].

Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR; en nombre del Comité Español Interdisciplinario de Prevención Cardiovascular y de la Sociedad Española de Cardiología.

Semergen. 2015 Apr;41(3):149-57. doi: 10.1016/j.semerg.2014.05.020. Epub 2014 Nov 14. Spanish.

PMID:
25450438
4.

[Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines].

Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR; Comité Español Interdisciplinario de Prevención Cardiovascular y de la Sociedad Española de Cardiología.

Clin Investig Arterioscler. 2015 Jan-Feb;27(1):36-44. doi: 10.1016/j.arteri.2014.09.001. Epub 2014 Nov 14. Spanish.

PMID:
25444651
5.

Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology position statement on dyslipidemia management. Differences between the European and American guidelines.

Lobos Bejarano JM, Galve E, Royo-Bordonada MÁ, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR; Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention; Spanish Society of Cardiology.

Rev Esp Cardiol (Engl Ed). 2014 Nov;67(11):913-9. doi: 10.1016/j.rec.2014.05.008. Epub 2014 Aug 3.

PMID:
25443815
6.

Cardiovascular news 2013/2014.

Cuende JI, Lahoz C, Armario P, García-Alegría J, Ena J, García de Casasola G, Mostaza JM.

Rev Clin Esp. 2015 January - February;215(1):33-42. doi: 10.1016/j.rce.2014.07.012. Epub 2014 Nov 1. English, Spanish.

PMID:
25439172
7.

Spanish Interdisciplinary Committee for Cardiovascular Disease Prevention and the Spanish Society of Cardiology Position Statement on Dyslipidemia Management. Differences Between the European and American Guidelines.

Lobos Bejarano JM, Galve E, Royo-Bordonada MA, Alegría Ezquerra E, Armario P, Brotons Cuixart C, Camafort Babkowski M, Cordero Fort A, Maiques Galán A, Mantilla Morató T, Pérez Pérez A, Pedro-Botet J, Villar Álvarez F, González-Juanatey JR; en nombre del Comité Español Interdisciplinario de Prevención Cardiovascular y de la Sociedad Española de Cardiología.

Rev Esp Cardiol. 2014 Aug 3. pii: S0300-8932(14)00317-0. doi: 10.1016/j.recesp.2014.05.008. [Epub ahead of print] English, Spanish.

8.

Blood pressure control is similar in treated hypertensive patients with optimal or with high-normal albuminuria.

Oliveras A, Armario P, Lucas S, de la Sierra A; COMBICONTROL Study Investigators.

Am J Hypertens. 2014 Sep;27(9):1185-90. doi: 10.1093/ajh/hpu039. Epub 2014 Mar 19.

PMID:
24646879
9.

[Control of blood pressure in hypertensive patients on combination therapy].

de la Sierra A, Oliveras A, Armario P, Lucas S; los investigadores del estudio COMBICONTROL.

Med Clin (Barc). 2015 Feb 20;144(4):145-50. doi: 10.1016/j.medcli.2013.09.033. Epub 2013 Dec 6. Spanish.

PMID:
24315774
10.

Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines.

Royo-Bordonada MA, Lobos Bejarano JM, Villar Alvarez F, Sans S, Pérez A, Pedro-Botet J, Moreno Carriles RM, Maiques A, Lizcano A, Lizarbe V, Gil Núñez A, Fornés Ubeda F, Elosua R, de Santiago Nocito A, de Pablo Zarzosa C, de Álvaro Moreno F, Cortés O, Cordero A, Camafort Babkowski M, Brotons Cuixart C, Armario P; en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC).

Neurologia. 2013 Aug 19. pii: S0213-4853(13)00131-X. doi: 10.1016/j.nrl.2013.04.011. [Epub ahead of print] English, Spanish.

11.

Resistant hypertension.

Armario P, Oliveras A, de la Sierra A.

Rev Clin Esp (Barc). 2013 Nov;213(8):388-93. doi: 10.1016/j.rce.2013.05.001. Epub 2013 Jul 1. English, Spanish.

PMID:
23827205
12.

[Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC) on the 2012 European Cardiovascular Prevention Guidelines].

Royo-Bordonada MÁ, Lobos Bejarano JM, Villar Alvarez F, Sans S, Pérez A, Pedro-Botet J, Moreno Carriles RM, Maiques A, Lizcano A, Lizarbe V, Gil Núñez A, Fornés Ubeda F, Elosua R, de Santiago Nocito A, de Pablo Zarzosa C, de Álvaro Moreno F, Cortés O, Cordero A, Camafort Babkowski M, Brotons Cuixart C, Armario P; Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC).

Rev Esp Salud Publica. 2013 Mar-Apr;87(2):103-20. doi: 10.4321/S1135-57272013000200002. Spanish.

13.

Urinary albumin excretion at follow-up predicts cardiovascular outcomes in subjects with resistant hypertension.

Oliveras A, Armario P, Sierra C, Arroyo JA, Hernández-del-Rey R, Vazquez S, Larrousse M, Sans L, Roca-Cusachs A, de la Sierra A.

Am J Hypertens. 2013 Sep;26(9):1148-54. doi: 10.1093/ajh/hpt074. Epub 2013 Jun 8.

PMID:
23747954
14.

[Statement of the Spanish Interdisciplinary Cardiovascular Prevention Committee (CEIPC for its Spanish acronym) on the 2012 European Cardiovascular Prevention Guidelines].

Royo-Bordonada MA, Lobos Bejarano JM, Villar Alvarez F, Sans S, Pérez A, Pedro-Botet J, Moreno Carriles RM, Maiques A, Lizcano A, Lizarbe V, Gil Núñez A, Fornés Ubeda F, Elosua R, de Santiago Nocito A, de Pablo Zarzosa C, de Álvaro Moreno F, Cortés O, Cordero A, Camafort Babkowski M, Brotons Cuixart C, Armario P; en nombre del Comité Español Interdisciplinario para la Prevención Cardiovascular (CEIPC).

Clin Investig Arterioscler. 2013 Jul-Aug;25(3):127-39. doi: 10.1016/j.arteri.2013.03.003. Epub 2013 May 31. Spanish.

PMID:
23726872
15.

Implementation of Spanish adaptation of the European guidelines on cardiovascular disease prevention in primary care.

Brotons C, Lobos JM, Royo-Bordonada MÁ, Maiques A, de Santiago A, Castellanos Á, Diaz S, Obaya JC, Pedro-Botet J, Moral I, Lizarbe V, Moreno R, Pérez A, Cordero A, Fornés-Ubeda F, Serrano-Saiz B, Camafort-Babkowski M, Elosua R, Sans S, de Pablo C, Gil-Nuñez A, de Álvaro-Moreno F, Armario P, Rico OC, Villar F, Lizcano Á.

BMC Fam Pract. 2013 Mar 18;14:36. doi: 10.1186/1471-2296-14-36.

16.

[The condition of the cardiovascular prevention in Spain].

Royo-Bordonada MÁ, Lobos JM, Brotons C, Villar F, de Pablo C, Armario P, Cortés O, Gil Nuñez A, Lizcano A, de Santiago A, Sans S; en nombre del Comité Español Interdisciplinario de Prevención Cardiovascular (CEIPC).

Med Clin (Barc). 2014 Jan 7;142(1):7-14. doi: 10.1016/j.medcli.2012.09.046. Epub 2013 Feb 22. Spanish.

PMID:
23433666
17.

Therapeutic strategies to improve control of hypertension.

Armario P, Waeber B.

J Hypertens. 2013 Mar;31 Suppl 1:S9-12. doi: 10.1097/HJH.0b013e32835d2c6c.

PMID:
23389085
18.

Increased pulse pressure is associated with left atrial enlargement in resistant hypertensive patients.

Armario P, Oliveras A, Hernández-Del-Rey R, Suárez C, Martell N, Ruilope LM, De La Sierra A; Investigators of Resistant Hypertension Registry of the Spanish Society of Hypertension.

Blood Press. 2013 Feb;22(1):39-44. doi: 10.3109/08037051.2012.701789.

PMID:
23305454
19.

Clinical differences between resistant hypertensives and patients treated and controlled with three or less drugs.

de la Sierra A, Banegas JR, Oliveras A, Gorostidi M, Segura J, de la Cruz JJ, Armario P, Ruilope LM.

J Hypertens. 2012 Jun;30(6):1211-6. doi: 10.1097/HJH.0b013e328353634e.

PMID:
22525201
20.

Abnormalities of vascular function in resistant hypertension.

de La Sierra A, Larrousse M, Oliveras A, Armario P, Hernández-Del Rey R, Poch E, Roca-Cusachs A.

Blood Press. 2012 Apr;21(2):104-9. doi: 10.3109/08037051.2011.622983. Epub 2011 Oct 24.

PMID:
22017418
Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Loading ...
Write to the Help Desk